Villaganas, Jhonny N.

HRN: 29-17-90  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2026
COTRIMOXAZOLE 960MG (TAB)
06/23/2026
06/30/2026
PO
960MG
MWF
ORAL CANDIDIASIS, Abscess, Lymphoma HIV St IV
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueEye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines